[
    [
        {
            "time": "2023-01-01",
            "original_text": "【山证医药】1月血制品批签发数据跟踪：1月批签发总体稳定，疫情下静丙需求量大幅提升",
            "features": {
                "keywords": [
                    "血制品",
                    "批签发",
                    "疫情",
                    "静丙",
                    "需求量"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【山证医药】1月血制品批签发数据跟踪：1月批签发总体稳定，疫情下静丙需求量大幅提升",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-03-20",
            "original_text": "富时罗素扩容A股因子至25% 3月20日收盘后生效",
            "features": {
                "keywords": [
                    "富时罗素",
                    "扩容",
                    "A股",
                    "因子"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "富时罗素扩容A股因子至25% 3月20日收盘后生效",
                "Correlation": 7,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 10,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-02-23",
            "original_text": "等闲不识医药面，核心资产总是牛！【西南证券医药|0223周报】",
            "features": {
                "keywords": [
                    "医药",
                    "核心资产"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "等闲不识医药面，核心资产总是牛！【西南证券医药|0223周报】",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-01-01",
            "original_text": "批签发同比快速增长，进度未受影响【安信医药战略推荐血制品系列9】批签发数据实时跟踪",
            "features": {
                "keywords": [
                    "批签发",
                    "同比增长",
                    "血制品"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "批签发同比快速增长，进度未受影响【安信医药战略推荐血制品系列9】批签发数据实时跟踪",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]